OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL
作者
Mark C. Genovese,Apinya Lertratanakul,Jaclyn K. Anderson,Kim Alexander Papp,William L. Tillett,Filip E Van den Bosch,Shigeyoshi Tsuji,Eva Dokoupilová,M. Keiserman,Xiayi Wang,Sheng Zhong,Patrick Zueger,Aileen L. Pangan,Philip J. Mease